|
|
|
|
||
Re: Bivalent might not be better than monovalentMissing in this discussion is the variant specific response. But pastryboy doesn’t get the science, and the author here failed to review the latest data presented at the last VRBAC meeting. Double is not impressive. But XBB1.5 is the future and that was nothing or a decent level of protective antibody. Detail details |
return to message board, top of board |